18519780

Source:http://linkedlifedata.com/resource/pubmed/id/18519780

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:18519780	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:18519780	lifeskim:mentions	umls-concept:C0030705	lld:lifeskim
pubmed-article:18519780	lifeskim:mentions	umls-concept:C1335729	lld:lifeskim
pubmed-article:18519780	lifeskim:mentions	umls-concept:C0001563	lld:lifeskim
pubmed-article:18519780	lifeskim:mentions	umls-concept:C0045093	lld:lifeskim
pubmed-article:18519780	lifeskim:mentions	umls-concept:C0205464	lld:lifeskim
pubmed-article:18519780	lifeskim:mentions	umls-concept:C2603343	lld:lifeskim
pubmed-article:18519780	lifeskim:mentions	umls-concept:C0205210	lld:lifeskim
pubmed-article:18519780	pubmed:issue	11	lld:pubmed
pubmed-article:18519780	pubmed:dateCreated	2008-6-3	lld:pubmed
pubmed-article:18519780	pubmed:abstractText	To determine the toxicity, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of oral gemcitabine (2',2'-difluorodeoxycytidine; dFdC) in patients with cancer.	lld:pubmed
pubmed-article:18519780	pubmed:language	eng	lld:pubmed
pubmed-article:18519780	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18519780	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:18519780	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18519780	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18519780	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18519780	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:18519780	pubmed:month	Jun	lld:pubmed
pubmed-article:18519780	pubmed:issn	1078-0432	lld:pubmed
pubmed-article:18519780	pubmed:author	pubmed-author:SlapakChristo...	lld:pubmed
pubmed-article:18519780	pubmed:author	pubmed-author:BeijnenJos...	lld:pubmed
pubmed-article:18519780	pubmed:author	pubmed-author:RosingHildeH	lld:pubmed
pubmed-article:18519780	pubmed:author	pubmed-author:PluimDickD	lld:pubmed
pubmed-article:18519780	pubmed:author	pubmed-author:SchellensJan...	lld:pubmed
pubmed-article:18519780	pubmed:author	pubmed-author:CalliesSophie...	lld:pubmed
pubmed-article:18519780	pubmed:author	pubmed-author:AndreValerie...	lld:pubmed
pubmed-article:18519780	pubmed:author	pubmed-author:JansenRobert...	lld:pubmed
pubmed-article:18519780	pubmed:author	pubmed-author:VeltkampSteph...	lld:pubmed
pubmed-article:18519780	pubmed:author	pubmed-author:Visseren-Grul...	lld:pubmed
pubmed-article:18519780	pubmed:author	pubmed-author:Kloeker-Rhoad...	lld:pubmed
pubmed-article:18519780	pubmed:issnType	Print	lld:pubmed
pubmed-article:18519780	pubmed:day	1	lld:pubmed
pubmed-article:18519780	pubmed:volume	14	lld:pubmed
pubmed-article:18519780	pubmed:owner	NLM	lld:pubmed
pubmed-article:18519780	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:18519780	pubmed:pagination	3477-86	lld:pubmed
pubmed-article:18519780	pubmed:meshHeading	pubmed-meshheading:18519780...	lld:pubmed
pubmed-article:18519780	pubmed:meshHeading	pubmed-meshheading:18519780...	lld:pubmed
pubmed-article:18519780	pubmed:meshHeading	pubmed-meshheading:18519780...	lld:pubmed
pubmed-article:18519780	pubmed:meshHeading	pubmed-meshheading:18519780...	lld:pubmed
pubmed-article:18519780	pubmed:meshHeading	pubmed-meshheading:18519780...	lld:pubmed
pubmed-article:18519780	pubmed:meshHeading	pubmed-meshheading:18519780...	lld:pubmed
pubmed-article:18519780	pubmed:meshHeading	pubmed-meshheading:18519780...	lld:pubmed
pubmed-article:18519780	pubmed:meshHeading	pubmed-meshheading:18519780...	lld:pubmed
pubmed-article:18519780	pubmed:meshHeading	pubmed-meshheading:18519780...	lld:pubmed
pubmed-article:18519780	pubmed:meshHeading	pubmed-meshheading:18519780...	lld:pubmed
pubmed-article:18519780	pubmed:meshHeading	pubmed-meshheading:18519780...	lld:pubmed
pubmed-article:18519780	pubmed:meshHeading	pubmed-meshheading:18519780...	lld:pubmed
pubmed-article:18519780	pubmed:meshHeading	pubmed-meshheading:18519780...	lld:pubmed
pubmed-article:18519780	pubmed:meshHeading	pubmed-meshheading:18519780...	lld:pubmed
pubmed-article:18519780	pubmed:meshHeading	pubmed-meshheading:18519780...	lld:pubmed
pubmed-article:18519780	pubmed:year	2008	lld:pubmed
pubmed-article:18519780	pubmed:articleTitle	Oral administration of gemcitabine in patients with refractory tumors: a clinical and pharmacologic study.	lld:pubmed
pubmed-article:18519780	pubmed:affiliation	Division of Experimental Therapy, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands. s.veltkamp@nki.nl	lld:pubmed
pubmed-article:18519780	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:18519780	pubmed:publicationType	Clinical Trial, Phase I	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:18519780	lld:pubmed